- βIdentified that IV acetaminophen causes CGM readings to spike 55β114 mg/dL above real blood sugar levels
- βFound the false spike peaks around 29 minutes post-dose, giving caregivers a specific danger window to watch
- βHighlights a critical hospital safety gap for AID system users that patients and providers can now proactively address
| Journal | JMA journal |
| Year | 2025 |
| Authors | Matsuyama, Meiri, Sawada |
| PMID | 41220554 |
What Was Studied and Why It Matters
Researchers in Japan reported a case that raises an important safety alert for people with type 1 diabetes using advanced insulin pump technology. The study, published in JMA Journal (2025), examined what happened when a boy with type 1 diabetes received intravenous (IV) acetaminophen β the active ingredient in Tylenol β while wearing a continuous glucose monitor (CGM) connected to an automated insulin delivery (AID) system.
AID systems, sometimes called "closed-loop" or "artificial pancreas" systems, automatically adjust insulin doses based on CGM readings. This makes accurate CGM data absolutely critical β a false reading can trigger the wrong insulin dose without any human decision-making in between.
What the Researchers Found
After the boy received IV acetaminophen for pain relief, his CGM readings shot up dramatically β but his actual blood sugar, measured by a traditional fingerstick test, barely moved. In plain terms, the CGM was lying.
- The false spike peaked about 29 minutes after the IV dose was given
- The CGM reading ran 55 to 114 mg/dL higher than the real blood sugar level
- The gap was even worse when actual blood sugar was on the lower side
- The problem occurred with each repeated dose of the medication
This matters enormously because an AID system seeing those falsely high numbers would automatically deliver extra insulin to "correct" a high that was never really there β potentially sending the patient into dangerous low blood sugar (hypoglycemia).
Why IV Acetaminophen Is a Bigger Concern Than the Pill Form
Most people know that oral acetaminophen can slightly affect CGM readings. However, IV acetaminophen reaches the bloodstream almost instantly and at higher concentrations, making the interference faster and more dramatic. This is particularly relevant in hospital settings, where IV pain medications are routinely given to patients who may also be wearing CGMs and insulin pumps.
What This Means for Real Patients and Caregivers
If you or your child uses a CGM β especially paired with an AID system or sensor-augmented pump β here is what you need to know:
- Tell every healthcare provider about your CGM and pump before receiving any IV medication, including acetaminophen
- Always verify with a fingerstick blood glucose test if your CGM shows a sudden, unexpected spike, especially in a medical setting
- Pause or override your AID system's automatic corrections if IV acetaminophen is being administered, and discuss this plan with your care team in advance
- Ask about alternatives for pain relief that do not interfere with CGM accuracy when possible
Keeping reliable supplies on hand β including fingerstick test strips for backup checks β is always wise. MDS Diabetes carries a full range of blood glucose monitoring supplies to ensure you are never caught without a way to verify your true glucose level when technology needs a second opinion.
Bottom Line
Intravenous acetaminophen can cause CGM sensors to display falsely high glucose readings within minutes of administration, with discrepancies large enough to trigger dangerous automatic insulin doses in AID systems. Patients, caregivers, and medical professionals must be aware of this risk and rely on fingerstick blood glucose testing to confirm readings whenever IV acetaminophen is used.
